FindTrial
Sign In

Evaluation of LipiFlow® treatment for meibomian gland dysfunction

Evaluation of LipiFlow® treatment for meibomian gland dysfunction - Evaluation of LipiFlow® treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018535
Enrollment
50
Registered
2015-08-04
Start date
2014-12-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of LipiFlow&amp

Interventions

LipiFlow&amp
reg
treatment

Sponsors

Itoh Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects fulfilled teh criteria of obstructive MGD determined by Japan MGD working group

Exclusion criteria

Exclusion criteria: MGD patient with any other ocular disease (except cataract) subjects without wriiten informed consent

Design outcomes

Primary

MeasureTime frame
Lipid layer thickness—

Secondary

MeasureTime frame
symptoms, tear brak-up time, temperature of eye and sourounded tissue, tear volume, etc.—

Countries

Japan

Contacts

Public ContactReiko Arita

Itoh Clinic Department of Ophthalmology

ritoh@za2.so-net.ne.jp048-686-5588

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026